These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 8612300)
21. Antibodies to TR2 (herpesvirus entry mediator), a new member of the TNF receptor superfamily, block T cell proliferation, expression of activation markers, and production of cytokines. Harrop JA; Reddy M; Dede K; Brigham-Burke M; Lyn S; Tan KB; Silverman C; Eichman C; DiPrinzio R; Spampanato J; Porter T; Holmes S; Young PR; Truneh A J Immunol; 1998 Aug; 161(4):1786-94. PubMed ID: 9712045 [TBL] [Abstract][Full Text] [Related]
22. Immunotherapy with agonistic anti-CD137: two sides of a coin. Sun Y; Chen JH; Fu Y Cell Mol Immunol; 2004 Feb; 1(1):31-6. PubMed ID: 16212918 [TBL] [Abstract][Full Text] [Related]
23. 4-1BB costimulation promotes human T cell adhesion to fibronectin. Kim YJ; Mantel PL; June CH; Kim SH; Kwon BS Cell Immunol; 1999 Feb; 192(1):13-23. PubMed ID: 10066342 [TBL] [Abstract][Full Text] [Related]
24. Anti-CD137 monoclonal antibody promotes the direct anti-tumor effect mediated by peripheral blood-derived human dendritic cells in vitro. Zhang L; Wang Q; Wang X; Ding P; Song J; Ma C; Sun W Cell Mol Immunol; 2004 Feb; 1(1):71-6. PubMed ID: 16212924 [TBL] [Abstract][Full Text] [Related]
25. Engagement of the CD137 (4-1BB) costimulatory molecule inhibits and reverses the autoimmune process in collagen-induced arthritis and establishes lasting disease resistance. Foell JL; Diez-Mendiondo BI; Diez OH; Holzer U; Ruck P; Bapat AS; Hoffmann MK; Mittler RS; Dannecker GE Immunology; 2004 Sep; 113(1):89-98. PubMed ID: 15312139 [TBL] [Abstract][Full Text] [Related]
26. 4-1BB-mediated immunotherapy of rheumatoid arthritis. Seo SK; Choi JH; Kim YH; Kang WJ; Park HY; Suh JH; Choi BK; Vinay DS; Kwon BS Nat Med; 2004 Oct; 10(10):1088-94. PubMed ID: 15448685 [TBL] [Abstract][Full Text] [Related]
27. Functional CD137 receptors are expressed by eosinophils from patients with IgE-mediated allergic responses but not by eosinophils from patients with non-IgE-mediated eosinophilic disorders. Heinisch IV; Bizer C; Volgger W; Simon HU J Allergy Clin Immunol; 2001 Jul; 108(1):21-8. PubMed ID: 11447378 [TBL] [Abstract][Full Text] [Related]
28. Humanization of agonistic anti-human 4-1BB monoclonal antibody using a phage-displayed combinatorial library. Son JH; Lee UH; Lee JJ; Kwon B; Kwon BS; Park JW J Immunol Methods; 2004 Mar; 286(1-2):187-201. PubMed ID: 15087232 [TBL] [Abstract][Full Text] [Related]
29. Novel T cell antigen 4-1BB associates with the protein tyrosine kinase p56lck1. Kim YJ; Pollok KE; Zhou Z; Shaw A; Bohlen JB; Fraser M; Kwon BS J Immunol; 1993 Aug; 151(3):1255-62. PubMed ID: 8335927 [TBL] [Abstract][Full Text] [Related]
30. 4-1BB gene expression in peripheral blood mononuclear cells from orthotopic liver transplant recipients with graft acceptance. Wan Y; Zheng S; Jia C; Yang J; Jin X; Zhao Z Chin Med J (Engl); 2003 Dec; 116(12):1854-9. PubMed ID: 14687473 [TBL] [Abstract][Full Text] [Related]
31. CD28-independent costimulation of T cells by OX40 ligand and CD70 on activated B cells. Akiba H; Oshima H; Takeda K; Atsuta M; Nakano H; Nakajima A; Nohara C; Yagita H; Okumura K J Immunol; 1999 Jun; 162(12):7058-66. PubMed ID: 10358148 [TBL] [Abstract][Full Text] [Related]
32. Genomic organization and chromosomal localization of the T-cell antigen 4-1BB. Kwon BS; Kozak CA; Kim KK; Pickard RT J Immunol; 1994 Mar; 152(5):2256-62. PubMed ID: 8133039 [TBL] [Abstract][Full Text] [Related]
33. Monoclonal antibodies, L-35 and L-36, define novel T cell activation antigens. Maino VC; Janszen ME J Immunol; 1986 Nov; 137(10):3093-9. PubMed ID: 3095423 [TBL] [Abstract][Full Text] [Related]
34. Involvement of 4-1BB (CD137)-4-1BBligand interaction in the modulation of CD4 T cell-mediated inflammatory colitis. Maerten P; Kwon BS; Shen C; De Hertogh G; Cadot P; Bullens DM; Overbergh L; Mathieu C; Van Assche G; Geboes K; Rutgeerts P; Ceuppens JL Clin Exp Immunol; 2006 Feb; 143(2):228-36. PubMed ID: 16412046 [TBL] [Abstract][Full Text] [Related]
35. The potential roles of 4-1BB costimulation in HIV type 1 infection. Wang S; Kim YJ; Bick C; Kim SH; Kwon BS AIDS Res Hum Retroviruses; 1998 Feb; 14(3):223-31. PubMed ID: 9491912 [TBL] [Abstract][Full Text] [Related]
36. 4-1BB costimulatory signals preferentially induce CD8+ T cell proliferation and lead to the amplification in vivo of cytotoxic T cell responses. Shuford WW; Klussman K; Tritchler DD; Loo DT; Chalupny J; Siadak AW; Brown TJ; Emswiler J; Raecho H; Larsen CP; Pearson TC; Ledbetter JA; Aruffo A; Mittler RS J Exp Med; 1997 Jul; 186(1):47-55. PubMed ID: 9206996 [TBL] [Abstract][Full Text] [Related]
37. Monoclonal antibodies directed against the T-cell activation molecule CD137 (interleukin-A or 4-1BB) block human lymphocyte-mediated suppression of tumor xenografts in severe combined immunodeficient mice. Sabel MS; Conway TF; Chen FA; Bankert RB J Immunother; 2000; 23(3):362-8. PubMed ID: 10838665 [TBL] [Abstract][Full Text] [Related]
38. Constitutive expression of 4-1BB on T cells enhances CD4+ T cell responses. Kim J; Choi SP; La S; Seo JS; Kim KK; Nam SH; Kwon B Exp Mol Med; 2003 Dec; 35(6):509-17. PubMed ID: 14749528 [TBL] [Abstract][Full Text] [Related]
39. Immunotherapy targeting 4-1BB and its ligand. Vinay DS; Kwon BS Int J Hematol; 2006 Jan; 83(1):23-8. PubMed ID: 16443548 [TBL] [Abstract][Full Text] [Related]
40. Tissue-specific regulation of IL-4 mRNA expression in human tonsil. Secrist H; Egan M; Peters MG J Immunol; 1994 Feb; 152(3):1120-6. PubMed ID: 7507959 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]